ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,822Medicare Part D Prescriptions Filled, Including Refills

Rank: 49 out of 151

$464K Total Retail Price of All Prescriptions

Rank: 55 out of 151

459 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
38% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 459 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

15% of this provider’s 459 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 9,222 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
HYDROCODONE-ACETAMINOPHEN 501 460 S3 1 10
LEVOTHYROXINE SODIUM 348 315 2 2
FUROSEMIDE 301 288 3 6
AMLODIPINE BESYLATE 294 284 4 3
METHADONE HCL 258 241 S2 5 146
SIMVASTATIN 255 254 6 1
PRAVASTATIN SODIUM 248 236 7 23
WARFARIN SODIUM 243 243 8 9
CITALOPRAM HBR 237 221 9 18
OMEPRAZOLE 193 185 10 4
LISINOPRIL 180 173 11 5
METOPROLOL TARTRATE 171 166 12 7
METOPROLOL SUCCINATE 150 141 13 21
GABAPENTIN 142 111 14 14
POTASSIUM CHLORIDE 138 138 15 19
METHYLPREDNISOLONE 136 128 16 91
ZOLPIDEM TARTRATE 133 124 17 17
TRIAMTERENE-HCTZ 131 131 18 68
LOSARTAN POTASSIUM 125 123 19 12
ATENOLOL 122 122 20 11
PREDNISONE 120 118 21 45
DIGOXIN 117 117 22 39
MIRTAZAPINE 113 113 23 28
ALENDRONATE SODIUM 107 107 24 26
LISINOPRIL-HYDROCHLOROTHIAZIDE 105 104 25 56
METFORMIN HCL 104 100 26 8
ATORVASTATIN CALCIUM 92 86 27 16
AZITHROMYCIN 89 84 28 36
BENAZEPRIL HCL 73 73 29 103
DONEPEZIL HCL 72 72 30 15
DILTIAZEM 24HR CD 72 72 30 136
FLUTICASONE PROPIONATE 72 68 30 35
CELEBREX 68 67 33 110
AMLODIPINE BESYLATE-BENAZEPRIL 64 64 34 89
LEVOFLOXACIN 64 57 34 80
KLOR-CON 10 63 63 36 95
LOSARTAN-HYDROCHLOROTHIAZIDE 62 62 37 59
NITROGLYCERIN PATCH 62 62 37 153
NEXIUM 60 57 39 44
LACTULOSE 58 57 40 101
SERTRALINE HCL 56 55 41 25
MELOXICAM 55 53 42 57
DIOVAN 53 50 43 33
TAMSULOSIN HCL 52 47 44 30
CYMBALTA 52 49 44 62
PREMARIN 52 52 R 44 228
SPIRONOLACTONE 52 51 44 72
CLOPIDOGREL 51 51 48 29
RANITIDINE HCL 50 50 49 32
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 27, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.